Publication | Closed Access

Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer

Breast OncologyPoor SurvivalMedicineCancer GrowthPathologyKeratin 17Cancer BiologyBreast CancerDermatologyOncologyRadiation OncologyCancer ResearchMammary Gland DevelopmentTumor BiologyEndocrine-related CancerSkin Cancer